Cancer stem cells converted from pluripotent stem cells and the cancerous niche

Journal of Stem Cells and Regenerative Medicine

Volumn 10, Issue 1, 2014, Pages 2-7

  Kasai, T ^a   Chen, L ^b   Mizutani, A ^a   Kudoh, T ^a   Murakami, H ^a   Fu, L ^c   Seno, M ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Tianjin Central Hospital of Gynecology Obstetrics   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; PHENOTYPE; PLURIPOTENT STEM CELL; REVIEW; STEM CELL NICHE; TISSUE SPECIFICITY; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

EID: 84899719487     PISSN: 09737154     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, Goldfinger N, Simansky D, Perlman M, Papa M, Yosepovich A, Rechavi G, Rotter V, Oren M (2009) Cancer cells suppress p53 in adjacent fibroblasts. Oncogene 28:933-936.
2. Chen L, Kasai T, Li Y, Sugii Y, Jin G, Okada M, Vaidyanath A, Mizutani A, Satoh A, Kudoh T, Hendrix MC, Salomon DS, Fu L, Seno M (2012) A model of cancer stem cells derived from mouse induced pluripotent stem cells. PLoS One 7:e33544.
3. Chen L, Mizutani A, Kasai T, Yan T, Jin G, Vaidyanath A, El-Aarag BY, Liu Y, Kudoh T, Salomon DS, Fu L, Seno M (2014) Mouse induced pluripotent stem cell microenvironment generates epithelial-mesenchymal transition in mouse Lewis lung cancer cells. Am J Cancer Res. 4:80-8.
4. Carette JE, Pruszak J, Varadarajan M, Blomen VA, Gokhale S, Camargo FD, Wernig M, Jaenisch R, Brummelkamp TR (2010) Generation of iPSCs from cultured human malignant cells. Blood. 115:4039-4042.
5. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344.
6. Costa FF, Seftor EA, Bischof JM, Kirschmann DA, Strizzi L, Arndt K, Bonaldo Mde F, Soares MB, Hendrix MJ (2009) Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 1:387-398.
7. Hu M, Polyak K (2008) Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18:27-34.
8. Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, Wicha MS, Nor JE (2010) Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res 70:9969-9978.
9. Laconi E (2007) The evolving concept of tumor microenvironments. Bioessays 29:738-744.
10. Moore KA, Lemischka IR (2006) Stem cells and their niches. Science 311:1880-1885.
11. Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT, Ying SY (2008) Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14:2115-2124.
12. Mani S, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
13. Matsuda S, Yan T, Mizutani A, Sota T, Hiramoto Y, Prieto-Vila M, Chen L, Satoh A, Kudoh T, Kasai T, Murakami H, Fu L, Salomon DS, Seno M (2013) Cancer stem cells maintain a hierarchy of differentiation by creating their niche. Int J Cancer in press. DOI: 10.1002/ijc.28648.
14. Miyoshi N, Ishii H, Nagai K, Hoshino H, Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y, Mori M (2010) Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA 107:40-45.
15. Nagai K, Ishii H, Miyoshi N, Hoshino H, Saito T, Sato T, Tomimaru Y, Kobayashi S, Nagano H, Sekimoto M, Doki Y, Mori M (2010) Long-term culture following ES-like geneinduced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells. Biochem Biophys Res Commun 395:258-263.
16. Ning N, Pan Q, Zheng F, Teitz-Tennenbaum S, Egenti M, Yet J, Li M, Ginestier C, Wicha MS, Moyer JS, Prince MEP, Xu Y, Zhang X-L, Huang S, Chang AE, Li Q (2012) Cancer stem cell vaccination confers significant antitumor immunity. Cancer Res 72:1853-1864.
17. Noh KH, Lee YH, Jeon JH, Kang TH, Mao CP, Wu TC, Kim TW (2012) Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype. Cancer Res 72:1717-1727.
18. O'Brien CA, Kreso A, Jamieson CHM (2010) Cancer stem cells and self-renewal. Clin. Cancer Res 16:3113-3120.
19. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
20. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ (2008) Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 105:4329-4334.
21. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824-828.
22. Scaffidi P, Misteli T (2011) In vivo generation of human cells with cancer stem cell properties. Nat Cell Biol 13:1051-1061.
23. Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 108:4274-4280.
24. Son MJ, Woolard K, Nam DH, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440-452.
25. Su YJ, Lai HM, Chan YW, Chen GY, Lee JL (2011) Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 30:3186-3199.
26. Sun C, Liu YK (2011) Induced pluripotent cancer cells: progress and application. J Cancer Res Clin Oncol 137:1-8.
27. Tzukerman M, Rosenberg T, Reiter I, Ben-Eliezer S, Denkberg G, Coleman R, Reiter Y, Skorecki K (2006) The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res 66:3792-3801.
28. Wang JC, Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15:494-501.
29. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829-833.
30. Werbowetski-Ogilvie TE, Bossé M, Stewart M, Schnerch A, Ramos-Mejia V, Rouleau A, Wynder T, Smith MJ, Dingwall S, Carter T, Williams C, Harris C, Dolling J, Wynder C, Boreham D, Bhatia M. (2009) Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 27:91-97.
31. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8:806-823.
32. Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, He X, Hervey-Jumper SL, Heth JA, Muraszko KM, DiMeco F, Vescovi AL, Fan X (2011) Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 71:6061-6072.